The Trump administration reportedly is bothered by the $18.9 billion trade deficit with Switzerland, which is mainly driven by pharmaceuticals.
While the tariffs do not appear to be an immediate threat, they could potentially affect Swiss pharma giants Novartis and Roche and other manufacturers that produce drugs in Switzerland, like Merck and Biogen.
Read the full report here.
More articles on pharmacy:
Novant Health to open health clinics inside Walgreens
GlaxoSmithKline recalls prescription heartburn drug globally
BIO CEO to step down at the end of 2020
